InvestorsHub Logo
Followers 14
Posts 860
Boards Moderated 0
Alias Born 07/18/2014

Re: None

Friday, 07/02/2021 12:45:24 AM

Friday, July 02, 2021 12:45:24 AM

Post# of 2219
I searched other biotechs for the phrase “identified deficiencies that preclude the continuation of the discussion of labeling and post marketing requirements/commitments at this time.”

This is what I found:

Cosmo Pharma drug Methylene Blue MMX
Status: FDA CRL, repeat Phase 3

$ATRS drug XYOSTED
Status: FDA Approved

Vanda Pharma drug Hetlioz (for jet lag)
Status: FDA denied

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ITRM News